Cover Image

Natural acetylcholinesterase inhibitors: A multi-targeted therapeutic potential in Alzheimer's disease

Alzheimer's disease (AD), the main dementia type accounting for over 70 % of the entire dementia population and exhibits progressive decline in memory and executive function. AD pathology is characterized by amyloid fibrils and neurofibrillary tangles. Acetylcholinesterase (AChE), an enzyme inv...

Full description

Saved in:

Bibliographic Details
Main Authors:	Kumar Gajendra (Author), G.K. Pratap (Author), D.V. Poornima (Author), Manjula Shantaram (Author), G. Ranjita (Author)
Format:	Book
Published:	Elsevier, 2024-08-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Naturally Occurring Acetylcholinesterase Inhibitors and Their Potential Use for Alzheimer's Disease Therapy
by: Thaiane Coelho dos Santos, et al.
Published: (2018)

Dual-target ligand discovery for Alzheimer's disease: triphenylphosphoranylidene derivatives as inhibitors of acetylcholinesterase and β-amyloid aggregation
by: Marwa El-Hussieny, et al.
Published: (2023)

Discovery of new acetylcholinesterase inhibitors for Alzheimer's disease: virtual screening and in vitro characterisation
by: Benoit David, et al.
Published: (2021)

Latest advances in dual inhibitors of acetylcholinesterase and monoamine oxidase B against Alzheimer's disease
by: Dajiang Zou, et al.
Published: (2023)

Molecular Multi-Target Approach for Human Acetylcholinesterase, Butyrylcholinesterase and <i>β</i>-Secretase 1: Next Generation for Alzheimer's Disease Treatment
by: Géssica Oliveira Mendes, et al.
Published: (2023)

Indene-Derived Hydrazides Targeting Acetylcholinesterase Enzyme in Alzheimer's: Design, Synthesis, and Biological Evaluation
by: Shraddha Manish Gupta, et al.
Published: (2022)

Study of neuroprotective activity of new acetylcholinesterase inhibitors TVA and TVS in experimental model of Alzheimer's disease
by: Hrachik V. Gasparyan, et al.
Published: (2022)

Novel harmine derivatives as potent acetylcholinesterase and amyloid beta aggregation dual inhibitors for management of Alzheimer's disease
by: Hongtao Du, et al.
Published: (2023)

Chromone hybrids as interleukin-6 and acetylcholinesterase inhibitor for treatment of Alzheimer's disease: Design, docking, synthesis and evaluation
by: Shivam Mishra, et al.
Published: (2024)

Novel ligand-based docking; molecular dynamic simulations; and absorption, distribution, metabolism, and excretion approach to analyzing potential acetylcholinesterase inhibitors for Alzheimer's disease
by: Subramaniyan Vijayakumar, et al.
Published: (2018)

Pharmacological Aspects of the Acetylcholinesterase Inhibitor Galantamine
by: Yukio Ago, et al.
Published: (2011)

Gut microbiota metabolites: potential therapeutic targets for Alzheimer's disease?
by: Shanshan Zhang, et al.
Published: (2024)

Design, synthesis and docking study of novel coumarin ligands as potential selective acetylcholinesterase inhibitors
by: Fatih Sonmez, et al.
Published: (2017)

Hierarchical Virtual Screening of Potential Insectides Inhibitors of Acetylcholinesterase and Juvenile Hormone from Temephos
by: Glauber V. da Costa, et al.
Published: (2019)

Synthesis, Docking and Acetylcholinesterase Inhibitory Evaluation of 1,3,4-Thiadiazole Derivatives as Potential Anti-Alzheimer Agents
by: Ahmad Mohammadi-Farani, et al.
Published: (2024)

Isolation and characterization of compounds from Nardostachys jatamansi targeting acetylcholinesterase inhibitors based on TLC-bioautography
Published: (2017)

Dyhidro-β-agarofurans natural and synthetic as acetylcholinesterase and COX inhibitors: interaction with the peripheral anionic site (AChE-PAS), and anti-inflammatory potentials
by: Julio Alarcón-Enos, et al.
Published: (2022)

Pharmacological Characterization of RS-1259, an Orally Active Dual Inhibitor of Acetylcholinesterase and Serotonin Transporter, in Rodents: Possible Treatment of Alzheimer's Disease
by: Yasuyuki Abe, et al.
Published: (2003)

Discovery of pyrrole derivatives as acetylcholinesterase-sparing butyrylcholinesterase inhibitor
by: Shouyuan Sun, et al.
Published: (2022)

Investigation of Experimental and In Silico Physicochemical Propertiesof Thiazole-Pyridinium Anti-Acetylcholinesterase Derivatives withPotential Anti-Alzheimer's Activity
by: Golaleh Ghotbi, et al.
Published: (2021)

The Role of NLRP3 Inflammasome in Alzheimer's Disease and Potential Therapeutic Targets
by: Tao Liang, et al.
Published: (2022)

Multi-Target Screening and Experimental Validation of Natural Products from Selaginella Plants against Alzheimer's Disease
by: Yin-Hua Deng, et al.
Published: (2017)

Advances on plant extracts and phytocompounds with acetylcholinesterase inhibition activity for possible treatment of Alzheimer's disease
by: Rashid Taqui, et al.
Published: (2022)

Multiomics Identification of Potential Targets for Alzheimer Disease and Antrocin as a Therapeutic Candidate
by: Alexander T. H. Wu, et al.
Published: (2021)

Evaluation of N-alkyl isatins and indoles as acetylcholinesterase and butyrylcholinesterase inhibitors
by: Kaitlyn N. Alcorn, et al.
Published: (2024)

Molecular interactions of an alkaloid euchrestifoline as a new acetylcholinesterase inhibitor
by: Fazal Ur Rehman, et al.
Published: (2013)

Isolation and characterization of acetylcholinesterase inhibitors from Piper longum L.
by: Z. Khatami*, et al.
Published: (2017)

Therapeutic Effects of Natural Drugs on Alzheimer's Disease
by: Yuan Ma, et al.
Published: (2019)

Novel tacrine-benzofuran hybrids as potential multi-target drug candidates for the treatment of Alzheimer's Disease
by: Gaia Fancellu, et al.
Published: (2020)

Current Pharmacotherapy and Multi-Target Approaches for Alzheimer's Disease
by: Siew Lee Cheong, et al.
Published: (2022)

Natural Products-Based Drugs: Potential Therapeutics against Alzheimer's Disease and other Neurological Disorders
Published: (2020)

Exploring the role of COX-2 in Alzheimer's disease: Potential therapeutic implications of COX-2 inhibitors
by: Nathalie Moussa, et al.
Published: (2023)

New 3-O-substituted xanthone derivatives as promising acetylcholinesterase inhibitors
by: Zi Han Loh, et al.
Published: (2021)

Synthesis and biological evaluation of fused dipyranoquinolinones as inhibitors of acetylcholinesterase with antioxidant properties
by: Evangelia-Eirini N. Vlachou, et al.
Published: (2022)

Natural compounds: Wnt pathway inhibitors with therapeutic potential in lung cancer
by: Xuetong Shen, et al.
Published: (2023)

Natural compounds as lactate dehydrogenase inhibitors: potential therapeutics for lactate dehydrogenase inhibitors-related diseases
by: Jung Ho Han, et al.
Published: (2023)

Natural isoquinoline alkaloids: Pharmacological features and multi-target potential for complex diseases
by: Erika Plazas, et al.
Published: (2022)

Synthesis of Novel Bis-Coumarin Derivatives as Potential Acetylcholinesterase Inhibitors: An In Vitro, Molecular Docking, and Molecular Dynamics Simulations Study
by: Zhila Zare-Akbari, et al.
Published: (2022)

Discovery of Novel Coumarin-Schiff Base Hybrids as Potential Acetylcholinesterase Inhibitors: Design, Synthesis, Enzyme Inhibition, and Computational Studies
by: Aso Hameed Hasan, et al.
Published: (2023)

Dendrimers in Alzheimer's Disease: Recent Approaches in Multi-Targeting Strategies
by: Cécile Arbez-Gindre, et al.
Published: (2023)